Tablet, Capsule, and Syrup Manufacturing - DPR

Description

Tablet, capsule, and syrup manufacturing refers to the pharmaceutical formulation and production of solid and liquid oral dosage forms used for the prevention, treatment, and management of a wide range of diseases. These dosage forms represent the most commonly prescribed and consumed medicines globally due to their convenience, accurate dosing, patient compliance, and cost-effectiveness. Tablets and capsules are solid oral dosage forms, while syrups are liquid formulations primarily used for pediatric, geriatric, and patients with swallowing difficulties.

Tablets are manufactured by compressing active pharmaceutical ingredients (APIs) with excipients such as binders, disintegrants, lubricants, and fillers into solid units. Capsules involve filling APIs into hard gelatin or vegetarian shells, whereas syrups are prepared by dissolving or suspending APIs in flavored, sweetened aqueous solutions. These dosage forms are widely used in therapies related to pain management, infections, cardiovascular diseases, diabetes, respiratory disorders, gastrointestinal issues, vitamins, and nutritional supplements.

Pharmaceutical oral formulations can be broadly classified based on dosage form and release profile. By dosage form, the category includes tablets (plain, coated, chewable, effervescent), capsules (hard gelatin, soft gelatin, vegetarian capsules), and syrups (medicated syrups, suspensions, oral solutions). By release mechanism, products include immediate-release, sustained-release, extended-release, and enteric-coated formulations. This wide classification enables manufacturers to cater to diverse therapeutic needs and patient groups.

The manufacturing process typically includes raw material dispensing, granulation (wet or dry), drying, blending, compression for tablets, capsule filling, syrup preparation, filtration, filling, sealing, labeling, and packaging. Advanced pharmaceutical facilities use automated granulators, fluid bed dryers, tablet compression machines, capsule filling machines, syrup manufacturing vessels, and liquid filling lines. Strict adherence to Good Manufacturing Practices (GMP), quality control testing, and validation protocols is mandatory to ensure safety, efficacy, and regulatory compliance.

Tablet, capsule, and syrup products are extensively used in hospitals, clinics, retail pharmacies, government health programs, institutional supply chains, and export markets. Growing healthcare access, increasing prevalence of chronic diseases, expanding generic medicine consumption, and rising demand for affordable medicines have significantly boosted this segment. India holds a strong position globally as a leading supplier of generic pharmaceutical formulations due to cost-efficient manufacturing, skilled manpower, and regulatory-compliant facilities.

Growth Drivers

• Rising prevalence of chronic and lifestyle-related diseases
• Increasing demand for affordable generic medicines
• Expansion of public healthcare and government drug programs
• Growing pediatric and geriatric population driving syrup demand
• Strong export demand for Indian pharmaceutical formulations

Market Size & Outlook

Global Market:

• The global pharmaceutical drug delivery (which includes tablets and capsules) market was valued at an estimated USD 1,831.1 billion in 2023 and stood at approximately USD 1,949.4 billion in 2024
• The global pharmaceutical industry driven strongly by formulations like tablets, capsules, and syrups is expected to continue growing substantially through the 2020s due to chronic disease prevalence, aging populations, broadening healthcare access, and R&D innovation.

India Market:

• The India pharmaceuticals market is estimated at around USD 60.32 billion in 2026 and is projected to grow to nearly USD 79.74 billion by 2031, at a 5.74% CAGR (2026-2031)